SCHEMBL26263147

SCHEMBL26263147

O=C(OCc1ccccc1)c1ccc(Nc2ccc(Cl)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.64
MAPT P10636 9/20 0.64
MEN1 O00255 7/20 0.64
NPSR1 Q6W5P4 2/20 0.64
TDP1 Q9NUW8 2/20 0.63
SLC6A2 P23975 1/20 0.63
SLC6A3 Q01959 1/20 0.63
LMNA P02545 2/20 0.62
RAB9A P51151 3/20 0.60
GAA P10253 2/20 0.60
ALDH1A1 P00352 4/20 0.55
HPGD P15428 1/20 0.55
NPC1 O15118 1/20 0.55
L3MBTL1 Q9Y468 3/20 0.55
CYP2C9 P11712 2/20 0.55
CYP2C19 P33261 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
HSP90AA1 P07900 1/20 0.53
KDM4E B2RXH2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26262973 0.91 KMT2A (0.71) KMT2AMAPTMEN1NPSR1TDP1
SCHEMBL2705832 0.91 KMT2A (0.76) KMT2AMAPTMEN1NPSR1TDP1
SCHEMBL10611772 0.89 KMT2A (0.73) KMT2AMAPTMEN1NPSR1TDP1
SCHEMBL26262975 0.85 KMT2A (0.64) KMT2AMAPTMEN1TDP1SLC6A2
SCHEMBL29193169 0.85 LMNA (0.81) KMT2AMAPTMEN1NPSR1TDP1
SCHEMBL2357688 0.84 KMT2A (0.76) KMT2AMAPTMEN1NPSR1TDP1
SCHEMBL312287 0.82 KMT2A (0.92) KMT2AMAPTMEN1TDP1SLC6A2
SCHEMBL7349720 0.81 KMT2A (0.71) KMT2AMAPTMEN1NPSR1TDP1
SCHEMBL11035112 0.81 NR4A2 (0.68) KMT2AMAPTMEN1NPSR1TDP1
SCHEMBL13698344 0.80 KMT2A (0.69) KMT2AMAPTMEN1NPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295200-A1 STAT5 and STAT6 Inhibitors and Uses Thereof UNIV MICHIGAN (US) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295200-A1 STAT5 and STAT6 Inhibitors and Uses Thereof STAT6, STAT5B, STAT5A KMT2A 1827/4885MAPT 3459/4885MEN1 2278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.